The “gateway” effect of e-cigarettes may be explained by a genetic liability to risk-taking.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
hall (2021)
Pilot Study to Detect Genes Involved in DNa Damage and Cancer in humans: Potential Biomarkers of Exposure to E-Cigarette aerosols.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
hamad (2021)
Occupational Exposure to Environmental Tobacco Smoke
Individual Clinical
Respiratory Toxicity
Secondary & Tertiary
Exposure
hammond (1995)
Identifying risk profiles for marijuana vaping among U.S. young adults by recreational marijuana legalization status: a machine learning approach.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
han (2022)
Inhaled nicotine in humans: effect on the respiratory and cardiovascular systems
Individual Clinical
Respiratory Toxicity
Relative Health Effects Of User
hansson (1994)
E-Cigarette Use, Small airway Fibrosis, and Constrictive Bronchiolitis.
Individual Clinical
Respiratory Toxicity
Relative Health Effects Of User
hariri (2022)
Electronic Cigarettes and Fecundability: Results From a Prospective Preconception Cohort Study.
Individual Clinical
Safety
Adverse Effects
harlow (2021)
Impact of the e-cigarette era on cigarette smoking among youth in the United States: a population-level study.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
harrell (2022)
anesthesia Implications of Patient Use of Electronic Cigarettes.
Individual Clinical
Safety
Adverse Effects
harris (2020)
Biomarkers of potential harm in people switching from smoking tobacco to exclusive e-cigarette use, dual use or abstinence: secondary analysis of Cochrane systematic review of trials of e-cigarettes for smoking cessation.
Individual Clinical
Biomarkers
Biomarkers Of Harm
hartmann-Boyce (2023)